Morgan Stanley Maintains Overweight on Exelon, Raises Price Target to $43
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Stephen Byrd has maintained an Overweight rating on Exelon (NASDAQ:EXC) and increased the price target from $42 to $43.
November 21, 2023 | 2:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley's analyst has reaffirmed an Overweight rating on Exelon and raised the price target, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst like Morgan Stanley suggests a positive outlook for Exelon, which could lead to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100